Literature DB >> 32583283

Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study.

Carsten H Meyer1, Peter Szurman2, Christos Haritoglou3,4, Mathias Maier5, Armin Wolf4, Lyubomyr Lytvynchuk6, Siegfried Priglinger4, Jost Hillenkamp7, Joachim Wachtlin8,9, Matthias Becker10, Stefan Mennel11, Michael J Koss3.   

Abstract

INTRODUCTION: Persisting macular holes (PMH) after surgical release of any epiretinal traction of the vitreous and adjacent membrane may rely on secondary firm adhesions between the retracted retina and adjacent retinal pigment epithelium. Secondary application of subretinal (SR)-fluid may release these adhesions followed by an anatomical closure.
METHODS: Twelve surgeons applied in a consecutive case series SR-fluid in 41 eyes with PMH and reported retrospectively their initial surgical, anatomical and functional experience with this approach.
RESULTS: The mean duration of the MH prior to SR-fluid application was 17 months (6-96 months). The mean age of the patients at the time of surgery was 72 years (54-88). The mean preoperative aperture diameter of the opening was 1212 μm (239-4344 μm), base diameter 649 μm (SD 320 μm). The mean preoperative BCVA prior to surgery was 0.1 (0.01-0.3). All patients (41/41) complained about reduced BCVA and a significant central scotoma (negative scotoma) in their central field of vision. The secondary closure rate for our PMH was 85.36% (35 out of 41 eyes) at 6 weeks after surgery. The postoperative BCVA improved to 0.22 (0.02-0.5). The application of SR-fluid was not associated with major intraoperative adverse effects.
CONCLUSION: Remaining SR-adhesions may inhibit PMH closure. Their release by application of SR-fluid will lead to a fast and immediate anatomical closure in many cases without serious adverse events.

Entities:  

Keywords:  Large aperture; Macular hole; Retreatment; Subretinal fluid; Vitrectomy; Vitreoretinal surgery

Year:  2020        PMID: 32583283     DOI: 10.1007/s00417-020-04735-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

Review 1.  Macular Holes: Main Clinical Presentations, Diagnosis, and Therapies.

Authors:  Elias Premi; Simone Donati; Lorenzo Azzi; Giovanni Porta; Cristian Metrangolo; Liviana Fontanel; Francesco Morescalchi; Claudio Azzolini
Journal:  J Ophthalmol       Date:  2022-04-11       Impact factor: 1.974

2.  Hints for Gentle Submacular Injection in Non-Human Primates Based on Intraoperative OCT Guidance.

Authors:  Gavin S W Tan; Zengping Liu; Tanja Ilmarinen; Veluchamy A Barathi; Caroline K Chee; Gopal Lingam; Xinyi Su; Boris V Stanzel
Journal:  Transl Vis Sci Technol       Date:  2021-01-07       Impact factor: 3.283

3.  Surgical Management of Recurrent and Persistent Macular Holes: A Practical Approach.

Authors:  Jessica L Cao; Peter K Kaiser
Journal:  Ophthalmol Ther       Date:  2021-09-07

4.  Internal Limiting Membrane Peeling and Gas Tamponade For Full-Thickness Macular Holes of Different Etiology - Is It Still Relevant?

Authors:  Andrii Ruban; Beáta Éva Petrovski; Goran Petrovski; Lyubomyr M Lytvynchuk
Journal:  Clin Ophthalmol       Date:  2022-10-13

5.  Combination of Inverted ILM Flap Technique and Subretinal Fluid Application Technique for Treatment of Chronic, Persistent and Large Macular Holes.

Authors:  Lyubomyr M Lytvynchuk; Andrii Ruban; Carsten Meyer; Knut Stieger; Andrzej Grzybowski; Gisbert Richard
Journal:  Ophthalmol Ther       Date:  2021-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.